Regeneron, Bayer’s Eylea ‘to remain king’ as analysts see ‘tepid’ response to biosimilar threats badams Thu, 02/24/2022 – […]
A woman in her 70s presented to the emergency department with a four day history of left sided […]
For 30 years, quality improvement approaches and tools have been used to improve the way in which healthcare […]
Covid-19Omicron booster study starts in UKA UK trial has been launched to test one of the world’s first […]
Updated Date: Wed, 16 Feb 2022 00:00:00 EST
Updated Date: Wed, 16 Feb 2022 00:00:00 EST
A new ‘cocktail’ drug under development could provide an effective and economical treatment to lessen symptoms for up […]
Rapid tests that give near instant results, without the need of a laboratory, offer much promise. But, to […]
Why doctors have a moral imperative to prescribe and support medical cannabis—an essay by David Nutt
A patient mentioned in this essay by David Nutt (BMJ 2022;376:n3114, doi:10.1136/bmj.n3114, published 26 January 2022) was identified […]
